|
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
|
FROM THE FIELDQuality Improvement By Providers: Market Developments Hinder Progress
Providers report maintaining, but not greatly enhancing, their quality improvement (QI) programs between 1999 and 2001. In addition, recent market developments are intensifying barriers to providers QI efforts. A notable exception is the tremendous attention to medical errors, which is stimulating patient-safety activities in hospitals. It is too early to tell if the momentum from these activities can be sustained and provide a spark for revolutionary changes in QI more broadly.
Over the past three decades improving health care quality has become increasingly important to policymakers, purchasers, consumers, and clinicians.1 Initial interest in quality improvement (QI) primarily stemmed from studies documenting marked variations in utilization rates and the absence of reasonable explanations for the variations. More recently, the release of two Institute of Medicine (IOM) reports in 1999 and 2001 has heightened interest in QI.2 The purpose of this paper is to describe the status of QI efforts by providers (hospitals and medical groups), the market forces shaping this activity, and the implications for public and private policymakers.3 First I describe the types of QI activities that providers report engaging in and their assessment of whether these activities changed much from 1999 to 2001. I then examine whether existing barriers to providers QI efforts are intensifying or receding and whether new facilitators are emerging. Third, I examine one particular QI activity: efforts to reduce medical errors. Unlike QI activities more broadly, major change in hospitals patient-safety activity has been reported. I conclude with a discussion of the policy implications of these findings.
This research is based on the Community Tracking Study (CTS), a longitudinal study that conducts site visits to twelve metropolitan communities every two years.4 Specifically, 202 semistructured interviews were conducted between June 2000 and March 2001 with managerial and clinical leaders of forty-eight hospitals and forty-eight medical groups. In each market the study team selected three to six hospital systems or hospitals: the largest systems or hospitals and one relatively small one. We also selected four of the largest medical groups and independent practice associations (IPAs) in the market.5 Respondents were asked about the market and regulatory environment; the criteria that plans use to select providers; plans products and payment arrangements; and providers primary strategies, including major changes in QI and care management activities. We also asked respondents how the market and provider organizations strategies had changed over the past two years, if at all. Well-established techniques were used to analyze the interview data, facilitated by qualitative data analysis software (Atlas.ti).6 Results from the prior two rounds of site visits (199697 and 199899) were used to put the current findings in context.
Status of QI efforts. Overall, hospital respondents reported maintaining but not greatly enhancing their QI activities. Respondents representing all forty-eight hospitals reported that their QI programs had not changed much over the past two years; six noted modest enhancements.
Hospital respondents mentioned a wide range of well-established QI activities (Exhibit 1
The most frequently mentioned QI activities were in the areas of leadership and accountability, information system infrastructure, and clinical guidelines.7 The specific activities most frequently mentioned included the following: (1) Appoint an individual or senior executive group to lead the effort (for example, hiring a chief medical officer [CMO] and having physician leaders report to the new CMO rather than to the chief executive officer). (2) Set and prioritize QI goals (some respondents noted that their hospitals were setting much more explicit, measurable QI goals for the first time; others indicated that their organization had reviewed and reprioritized goals), such as using QI tools to address new problems like emergency room crowding and delays.8 (3) Upgrade information technology capability. Respondents reported that their hospitals were upgrading their information systems and Internet capability. Many stated that their hospitals were working toward an electronic medical record (EMR). Five hospitals reported already having an EMR, although four of these had them only partially implemented. (4) Implement additional clinical guidelines. Hospitals were expanding the number of clinical conditions for which they implemented guidelines. Examples included acute myocardial infarction, pneumonia, and HIV. Some respondents also noted developing guidelines for selected chronic conditions such as congestive heart failure, asthma, and diabetes. These findings suggest that many hospitals QI activities remain in a relatively early, developmental stage. However, several hospitals reported QI activities that are more advanced (such as routinely monitoring performance via key measures and comparing performance against national benchmarks). Respondents from academic medical centers (AMCs) and their affiliated systems reported using a wider range of QI tools in more areas of the hospital and system. Likewise, respondents from all forty-eight medical groups reported no major changes in their QI activities. As did hospitals, medical groups most frequently mentioned implementing clinical guidelines and upgrading information system technology. They also often mentioned medical chart review as an example of QI activities they were pursuing. More established medical groups, such as Harvard Vanguard, reported greater breadth and depth of QI activity. For example, they had more guidelines in place and reported being able to collect and use outcome data related to them. Overall, QI efforts did not change greatly over the two years prior to the 2000/01 visits. In addition, the types of activities mentioned suggest that most hospitals and medical groups quality infrastructure could be much improved.
Recent marketwide plan and provider developments are intensifying barriers to greater QI efforts. Four important developments are (1) increased financial pressure; (2) the continued decline of tightly managed HMOs and capitation; (3) strained plan-provider relationships; and (4) retrenchment of organized delivery system (ODS) strategies and structures. In contrast, only one new facilitator of QI activity was emerging: new payment arrangements that reward quality. Increased financial pressure. Respondents reported that the financial pressure they had experienced during the previous two years was qualitatively different from what they experienced in the mid-1990s. Downward pressure on payment rates came from all payers simultaneously, while costs began to rise. First, payment reductions stipulated in the Balanced Budget Act (BBA) of 1997 began to hit providers as provisions of the act were implemented. Medicare constitutes a substantial portion of providers revenue (3070 percent) and had been a relatively generous payer before the BBA.9 Consequently, when Medicare payment reductions took effect, providers found it difficult to make up the revenue. The Balanced Budget Refinement Act (BBRA) of 1999 eased some of these payment reductions, but many providers continued to struggle. Second, HMO payment rates increasingly were used as benchmarks for other plan product payment rates, and for some providers managed care accounted for a greater portion of their total business. Some respondents noted that they might have unwittingly helped to create "dysfunctional markets" (that is, markets in which payment rates were artificially low and unsustainable) by giving managed care plans deep discounts in hopes of securing volume. However, increased volume did not necessarily flow from such contracts because of broad plan-provider networks. In addition, plans now expected similar payment rates and discounts for their other products (such as preferred provider organizations, or PPOs). While revenues were declining, costs were going up. Hospital respondents noted increased labor costs because of workforce shortages and rising technology and pharmaceutical costs. Medical-group respondents primarily noted increased practice overhead costs resulting from billing, regulatory, and liability demands. These financial pressures resulted in reduced or negative margins for both hospitals and medical groups. Many hospitals and physicians (particularly specialists) successfully pushed back on private plans and secured higher payment rates, which will help to improve their financial situation in the future.10 Yet some providers continue to struggle. In a number of CTS markets (such as Boston, northern New Jersey, and Phoenix) there was a growing gap between those hospitals with and without financial resources.11 Continued decline of tightly managed HMOs and capitation. In the first two rounds of site visits, there were signs that HMOs were not growing as rapidly as anticipated and that less restrictive forms of managed care were in greatest demand.12 During our most recent site visits, respondents reported that tightly managed care plans and capitated payment would not grow and develop as anticipated. Providers cited two market developments to support this conclusion. First, the majority of privately insured persons in the CTS markets were still enrolled in non-HMO products. The average HMO penetration rate for the twelve markets in 2000 was 28.4 percent, ranging from 11.2 percent to 43.8 percent. HMO enrollment actually declined in four markets between 1996 and 2000 (Lansing, Miami, Seattle, and Syracuse).13 In two other markets HMO enrollment increased moderately (less than 10 percent), and in the remaining six markets it grew more substantially (on average 43 percent) on a small base. Second, HMOs remained just one plan product among many, and they were becoming less restrictive.14 Rather than selectively contracting with providers, HMOs now included almost all providers. Consequently, provider networks were overlapping and largely indistinguishable. Plans were also loosening some utilization management (UM) strategies that previously had constrained enrollees choice of providers and use of services.15 A large degree of capitation (shared, global, or professional) was the exception rather than the rule.16 In the single market where risk was extensive (Orange County), these arrangements were stable but not growing. In the remaining markets capitation was more moderate or limited, and risk arrangements were being retrenched or rejected. As noted, one new development that might mitigate the move away from tightly managed HMOs and capitation was the emergence of new payment arrangements that reward providers for meeting QI targets. These payment arrangements recently emerged in three CTS markets (Boston, Orange County, and Seattle) and occurred on a very limited basis in four others (Lansing, Miami, northern New Jersey, and Phoenix). Depending on the market and plan, physicians receive a bonus of 410 percent for meeting quality goals, particularly measures related to Health Plan Employer Data and Information Set (HEDIS) indicators and patient satisfaction. It is unclear at present if these new payment arrangements will provide the mix of incentives necessary for major QI change. On the one hand, these arrangements are similar to previous payment arrangements that were not very effective (for example, withholds with "upside risk," that is, receiving some or all of the withheld amount if performance targets are met). On the other hand, these payment arrangements may truly be different, in terms of both the nature of the incentive (that is, bonus versus withhold) and the types of measures used to assess performance (for example, chronic care management, or patient satisfaction versus utilization). As one respondent noted, "Its easier to pull someone into the future than to kick them out of the past." Plan-provider competition rather than collaboration. Research from previous CTS rounds noted competition between plans and providers for control over care management and the strained relationships that resulted.17 Without cooperation between plans and providers, QI initiatives are likely to be less effective. During the current round of site visits, respondents noted that competition and strained relationships remained despite the easing of some unpopular UM strategies (such as prospective review).18 Moreover, competition and conflict had been exacerbated by several developments. First, providers reported that many plans could not share data with them in a timely and useful manner. Some plans information systems were taxed by mergers or rapid growth. Respondents reported that others had fewer plan staffers than before working with them to improve reports. Even hospital systems and medical groups with sophisticated information systems relied on plans for certain data (such as out-of-network utilization). Second, providers reported that plans have not helped to educate patients about the potential value of ODSs because plans want to market and support consumer choice. For example, a hospital system and its affiliated physician-hospital organization (PHO) in Boston asked plans to make it clear to enrollees via their provider handbooks that when they choose a primary care physician they are also selecting a provider subsystem or network (affiliated specialists and hospitals). This step would help the system to better manage the financial risk that they assumed for these enrollees and potentially better manage patients care. Plans were reluctant to clarify this information for enrollees, wishing to avoid the appearance of limiting provider access and choice. Finally, plans were increasingly launching disease and care management programs that they had developed and implemented themselves or had contracted with a regional or national firm to provide.19 Respondents from local provider organizations that had worked to develop their own care management infrastructure were frustrated that plans were not contracting with them for such services. They also were doubtful that these plan-led programs ultimately would be successful, particularly those administered by regional or national firms. Such arrangements made communication and collaboration more difficult because there was an additional party to the local plan-provider relationshipone that was difficult to get to know since it was generally located in another city or state. Retrenchment of ODS strategies and structures. Providers primary response to these market developments was to retrench their strategies and structures, which had largely been shaped by the goal of establishing an ODS. One major strategic shift was to reemphasize high-tech, profitable inpatient and outpatient specialty services (such as cardiology, oncology, and orthopedics) and amenities.20 Forty-four percent of the systems and hospitals interviewed reported that they were expanding specialty care centers (inpatient and outpatient), and 35 percent were expanding niche specialty services. Hospitals also increasingly focused on attracting and retaining "star" specialists who could develop these specialty programs. Hospitals also continued to restructure PHOs designed to accept risk and integrate care.21 For example, hospitals in the twelve CTS markets having a PHO declined from 36.5 percent in 1996 to 30 percent in 2000.22 Respondents from the remaining PHOs indicated that their organizations had not grown in number of contracts or covered lives; in some these had declined. Owned medical groups were downsized, and a variety of steps were taken to make them more productive. Recent research suggests that hospitals intense focus on increased productivity may alienate physicians, making it more difficult to engage them in future QI efforts.23 The consolidation of independent physicians into larger medical groups potentially more capable of improving quality has lagged behind the creation of hospital-based ODSs in the CTS markets.24 During the 200001 site visits there was little evidence that larger medical groups were developing, with physician consolidation efforts largely at a standstill. Status of patient-safety efforts. Unlike QI activities more generally, hospital respondents reported major changes in patient-safety activities, largely because hospitals previously had not focused on this quality problem. One market observer noted, "Hospitals have come a long way. Two years ago their idea of patient safety was to salt the sidewalk when it snowed."
As with QI more generally, hospital respondents reported engaging in a wide variety of patient-safety activities (Exhibit 2
Barriers and facilitators. Although hospitals were in the early implementation stages, respondents noted four barriers to patient safety. The first was cost. Several hospital respondents likened patient safety to unfunded mandates: something they had to do but for which they were unlikely to be sufficiently compensated. A second barrier was liability. Since policymakers were considering mandatory error reporting, this issue was increasingly salient. Third, many recommended steps to reduce errors have not been rigorously researched, leading the AHA to call for a "more inclusive" approach to patient safety initiatives.27 Finally, physicians resistance can present challenges. One hospital reported stopping an intensivist program after some attending physicians threatened to leave the institution. The use of an intensivist may disrupt continuity of care and precludes the attending physician from providing care in the ICU and billing for those services, since responsibility is transferred to the intensivist. Despite these barriers, hospital respondents noted that some forces in local markets facilitated major change in patient safety. Great state and local interest and activity had been generated by the IOM reports and by national-level efforts to address patient safety. Many states were considering, or had passed, legislation related to patient safety.28 Hospital respondents in California mentioned legislation that mandated hospitals to submit plans in 2002 for information system improvements to reduce medication errors and to have such systems operational by 2005.29 Hospital respondents in New York and Washington states reported that government agencies were reexamining existing error reporting requirements and asking them for input about how they might be improved. Large employers in three CTS markets (Boston, northern New Jersey, and Seattle) were participating in the Leapfrog Group and in two others (Lansing and Orange County) were raising awareness of patient-safety issues through other initiatives. Leapfrog recommended two of three activities hospital respondents frequently reported (CPOE systems and use of intensivists to staff ICUs).30 Several state professional associations (of doctors and nurses, hospitals, and health plans) also had launched initiatives of their own. For example, the New Jersey Hospital Association announced the creation of a Quality Institute with a $250,000 annual budget.31 Finally, and perhaps most importantly, consumers became much more aware of medical errors. Hospital respondents noted that the local media extensively covered the release of the IOM reports and related stories. In addition, they felt that patient safety was such a basic concern that consumers would be more likely to seek out, and use, information provided about hospital performance in this area.
Findings from the 2000/01 CTS site visits are consistent with the IOMs assessment that enormous changes are required to stimulate major improvements in quality.32 Barriers far outweighed facilitators; in fact, only one potential facilitator, new payment arrangements that reward providers for meeting QI targets, was emerging in these local markets. An important exception to this is the tremendous attention to medical errors and patient safety and the degree of hospital activity it stimulated. Early patient-safety initiatives were widespread in the CTS markets and had great momentum. Facilitators of patient-safety efforts now outweigh barriers. These findings raise two important policy questions. First, can interest and improvement in patient safety be sustained? If so, will patient safety be a spark for the more revolutionary, systemic changes called for in the IOMs reports? On the one hand, patient safety is compelling and provides a smaller set of QI activities on which to focus. On the other hand, patient safety may encounter some of the same barriers as QI efforts in the longer term. Future market developments, and policymakers responses to them, will ultimately provide the answers to these questions. The most important market development likely to affect providers QI efforts in the short term is rising costs. Double-digit premium increases have returned, and hospital costs recently surpassed drug costs as the key driver of total health care cost increases.33 Public and private purchasers resolve to slow cost increases is likely to intensify; however, the way they address the problem will have a sizable impact on providers incentives for improving quality. Greater focus on quality and patient safety would increase the likelihood that cost will not take on more weight in the value equation. Early patient-safety efforts illustrate that much can be accomplished in a short time when attention is focused on quality. If all key partiespolicymakers, purchaser, plans, providers, and consumersdedicated similar energy to QI more broadly, major change could result.
Kelly Devers is a health researcher at the Center for Studying Health System Change in Washington, D.C. The author gratefully acknowledges the Community Tracking Studys provider research team and administrative staff, as well as the interview respondents who contributed their time and insights. The author also thanks Paul Ginsburg, Cara Lesser, and the anonymous reviewers for their valuable comments. The Robert Wood Johnson Foundation provided support for this research.
| |||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||